Clinical Trial Update: Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures [Phase 3]

View source ↗

Summary

A Phase 3 extension study reports long-term safety and efficacy of pregabalin as monotherapy for partial seizures; completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2012-09-11